Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05316350 · ClinicalTrials.gov registry record · NA
Withings ECG-app Study
A NA study, sponsored by Withings.
- Completed
- Registry status
- NA
- Development phase
- 685
- Enrollment target
NCT05316350: Completed NA study, sponsored by Withings.
NCT05316350 is a NA study that has completed, run by Withings. The registered enrollment target is 685 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05316350, a NA study, has completed, sponsored by Withings.
- COMPLETED
- Registry status
- NA
- Development phase
- 685 participants
- Enrollment target
Study Summary
The aim of the study is to evaluate the performance of Withings HWA10 with embedded Withings ECG-app in the automatic detection of atrial fibrillation
Primary Outcome
Sensitivity (percentage of true positives) in detecting AF from conclusive recordings generated by the software under test, that is recordings resulting in a classification of AF or SR by the SUT, compared to the reference 12-lead ECG.
Interventions
- DEVICE Electrocardiogram recording
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
What the finished NCT05316350 record still lists
NCT05316350 is an interventional study that assigns participants to a tested intervention. The registered 685 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 1 intervention - of which Electrocardiogram recording is the first listed.
NCT05316350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05316350 about?
NCT05316350 is a clinical study titled "Withings ECG-app Study". The aim of the study is to evaluate the performance of Withings HWA10 with embedded Withings ECG-app in the automatic detection of atrial fibrillation
What is the current status of trial NCT05316350?
This trial is currently completed. It is a NA study. The enrollment target is 685 participants. The study started on 2022-07-15. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05316350?
The interventions under investigation include: Electrocardiogram recording (DEVICE).
Who is sponsoring clinical trial NCT05316350?
This trial is sponsored by Withings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05316350's enrollment target sits among peer trials
685 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- NCT06459180 · 686 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI